Identification of α1A-adrenoceptor selective antagonists for the treatment of benign prostatic hyperplasia

被引：15

作者：

Lagu, B ^{[1
]}

机构：

[1] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA

来源：

DRUGS OF THE FUTURE | 2001年 / 26卷 / 08期

关键词：

D O I：

10.1358/dof.2001.026.08.662740

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：757 / 765

页数：9

共 49 条

[1] DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS - 2-HETEROSUBSTITUTED 4-ARYL-1,4-DIHYDRO-6-METHYL-5-PYRIMIDINECARBOXYLIC ACID-ESTERS AS POTENT MIMICS OF DIHYDROPYRIDINES [J].

ATWAL, KS ;

ROVNYAK, GC ;

SCHWARTZ, J ;

MORELAND, S ;

HEDBERG, A ;

GOUGOUTAS, JZ ;

MALLEY, MF ;

FLOYD, DM .

JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (05) :1510-1515

[2] In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective α1A receptor antagonists for the treatment of benign prostatic hyperplasia [J].

Barrow, JC ;

Nantermet, PG ;

Selnick, HG ;

Glass, KL ;

Rittle, KE ;

Gilbert, KF ;

Steele, TG ;

Homnick, CF ;

Freidinger, RM ;

Ransom, RW ;

Kling, P ;

Reiss, D ;

Broten, TP ;

Schorn, TW ;

Chang, RSL ;

O'Malley, SS ;

Olah, TV ;

Ellis, JD ;

Barrish, A ;

Kassahun, K ;

Leppert, P ;

Nagarathnam, D ;

Forray, C .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2703-2718

[3]

BARROW JC, 2000, BIOORG MED CHEM LETT, V10, P2705

[4] Toward the development of α1a adrenergic receptor antagonists [J].

Bock, MG ;

Patane, MA .

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35, 2000, 35 :221-230

[5]

Broten T, 1999, FASEB J, V13, pA142

[6] In vitro studies on L-771,688 (SNAP 6383), a new potent and selective α1A-adrenoceptor antagonist [J].

Chang, RSL ;

Chen, TB ;

O'Malley, SS ;

Pettibone, DJ ;

DiSalvo, J ;

Francis, B ;

Bock, MG ;

Freidinger, R ;

Nagarathnam, D ;

Miao, SW ;

Shen, QR ;

Lagu, B ;

Dhar, TGM ;

Tyagarajan, S ;

Marzabadi, MR ;

Wong, WC ;

Gluchowski, C ;

Forray, C .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 409 (03) :301-312

[7] Inhibition by tamsulosin of tension responses of human hyperplastic prostate to electrical field stimulation [J].

Chueh, SC ;

Guh, JH ;

Chen, J ;

Lai, MK ;

Ko, FN ;

Teng, CM .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 305 (1-3) :177-180

[8] Design and synthesis of novel α1a adrenoceptor-selective antagonists.: 2.: Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety [J].

Dhar, TGM ;

Nagarathnam, D ;

Marzabadi, MR ;

Lagu, B ;

Wong, WC ;

Chiu, G ;

Tyagarajan, S ;

Miao, SW ;

Zhang, FQ ;

Sun, WY ;

Tian, D ;

Shen, QR ;

Zhang, J ;

Wetzel, JM ;

Forray, C ;

Chang, RSL ;

Broten, TP ;

Schorn, TW ;

Chen, TB ;

O'Malley, S ;

Ransom, R ;

Schneck, K ;

Bendesky, R ;

Harrell, CM ;

Vyas, KP ;

Zhang, KY ;

Gilbert, J ;

Pettibone, DJ ;

Patane, MA ;

Bock, MG ;

Freidinger, RM ;

Gluchowski, C .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (23) :4778-4793

[9]

Forray, 1999, Expert Opin Investig Drugs, V8, P2073, DOI 10.1517/13543784.8.12.2073

[10]

FORRAY C, 1994, MOL PHARMACOL, V45, P703

← 1 2 3 4 5 →